64Cu-ATSM and 18FDG PET uptake and 64Cu-ATSM autoradiography in spontaneous canine tumors: comparison with pimonidazole hypoxia immunohistochemistry

[1] Thomlinson RH(1955)The histological structure of some human lung cancers and the possible implications for radiotherapy Br J Cancer 9 539-549

[2] Gray LH(2008)Hypoxia and aggressive tumor phenotype: implications for therapy and prognosis Oncologist 13 21-26

[3] Vaupel P(2007)Hypoxia in cancer: significance and impact on clinical outcome Cancer Metastasis Rev 26 225-239

[4] Vaupel P(2006)PET imaging of tumour hypoxia Cancer Imaging 6 S117-S121

[5] Mayer A(2007)Imaging oxygenation of human tumours Eur Radiol 17 861-872

[6] Padhani A(2008)Molecular imaging of hypoxia J Nucl Med 49 129S-148S

[7] Padhani AR(2009)Assessing tumor hypoxia by positron emission tomography with Cu-ATSM Q J Nucl Med Mol Imaging 53 193-200

[8] Krohn KA(2007)Cu-ATSM: a radiopharmaceutical for the PET imaging of hypoxia Dalton Trans 43 4893-4902

[9] Lewis JS(2001)Tumor uptake of copper-diacetyl-bis(N(4)-methylthiosemicarbazone): effect of changes in tissue oxygenation J Nucl Med 42 655-661

[10] Alber M(2006)Intertumoral differences in hypoxia selectivity of the PET imaging agent 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone) J Nucl Med 47 989-998

[1] Thomlinson RH(1955)The histological structure of some human lung cancers and the possible implications for radiotherapy Br J Cancer 9 539-549

[2] Gray LH(2008)Hypoxia and aggressive tumor phenotype: implications for therapy and prognosis Oncologist 13 21-26

[3] Vaupel P(2007)Hypoxia in cancer: significance and impact on clinical outcome Cancer Metastasis Rev 26 225-239

[4] Vaupel P(2006)PET imaging of tumour hypoxia Cancer Imaging 6 S117-S121

[5] Mayer A(2007)Imaging oxygenation of human tumours Eur Radiol 17 861-872

[6] Padhani A(2008)Molecular imaging of hypoxia J Nucl Med 49 129S-148S

[7] Padhani AR(2009)Assessing tumor hypoxia by positron emission tomography with Cu-ATSM Q J Nucl Med Mol Imaging 53 193-200

[8] Krohn KA(2007)Cu-ATSM: a radiopharmaceutical for the PET imaging of hypoxia Dalton Trans 43 4893-4902

[9] Lewis JS(2001)Tumor uptake of copper-diacetyl-bis(N(4)-methylthiosemicarbazone): effect of changes in tissue oxygenation J Nucl Med 42 655-661

[10] Alber M(2006)Intertumoral differences in hypoxia selectivity of the PET imaging agent 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone) J Nucl Med 47 989-998